drugset / Trial / NCT00157729

MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)

NCT00157729

Phase 2 Completed 160 enrolled Medicure
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether MC-1 alone and in combination with an ACE inhibitor is effective in reducing blood pressure and metabolic dysfunctions associated with diabetes

Timeline

Start
2004-08
Primary completion
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Pyridoxal 5'-Phosphate Unknown